531 related articles for article (PubMed ID: 11045642)
1. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
[TBL] [Abstract][Full Text] [Related]
2. Sensitization and sensitivity: defining the unsensitized patient.
Gebel HM; Bray RA
Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
[TBL] [Abstract][Full Text] [Related]
3. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
[TBL] [Abstract][Full Text] [Related]
5. Conundrums with FlowPRA beads.
Gebel HM; Harris SB; Zibari G; Bray RA
Clin Transplant; 2002; 16 Suppl 7():24-9. PubMed ID: 12372040
[TBL] [Abstract][Full Text] [Related]
6. Relationship between CDC cross-match in liver recipients and antibody screening by flow cytometry.
Muro M; Sánchez-Bueno F; Marín L; Torío A; Moya-Quiles MR; Minguela A; Montes O; Guerra N; Montes M; Pérez-López MJ; Robles R; Ramirez P; García-Alonso AM; Parrilla P; Alvarez-López MR
Transplant Proc; 2003 Aug; 35(5):1894-5. PubMed ID: 12962837
[TBL] [Abstract][Full Text] [Related]
7. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
9. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.
Kerman RH; Susskind B; Buelow R; Regan J; Pouletty P; Williams J; Gerolami K; Kerman DH; Katz SM; Van Buren CT; Kahan BD
Transplantation; 1996 Jul; 62(2):201-5. PubMed ID: 8755816
[TBL] [Abstract][Full Text] [Related]
10. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
11. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens.
Bartel G; Wahrmann M; Exner M; Regele H; Schillinger M; Hörl WH; Böhmig GA
Transplantation; 2007 Mar; 83(6):727-33. PubMed ID: 17414705
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
[TBL] [Abstract][Full Text] [Related]
13. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients.
Wahrmann M; Exner M; Schillinger M; Haidbauer B; Regele H; Körmöczi GF; Hörl WH; Böhmig GA
Am J Transplant; 2006 May; 6(5 Pt 1):1033-41. PubMed ID: 16611341
[TBL] [Abstract][Full Text] [Related]
14. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
[TBL] [Abstract][Full Text] [Related]
15. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome.
Tambur AR; Pamboukian SV; Costanzo MR; Herrera ND; Dunlap S; Montpetit M; Heroux A
Transplantation; 2005 Oct; 80(8):1019-25. PubMed ID: 16278580
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation.
Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H
Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
[TBL] [Abstract][Full Text] [Related]
18. Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization.
Kato T; Mizutani K; Terasaki P; Quintini C; Selvaggi G; Thompson J; Ruiz P; Tzakis A
Transplant Proc; 2006; 38(6):1735-7. PubMed ID: 16908266
[TBL] [Abstract][Full Text] [Related]
19. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
Schönemann C; Groth J; Leverenz S; May G
Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
[TBL] [Abstract][Full Text] [Related]
20. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
